Phenben/Ivermectin 148/4mg – 60 Tablets

Description

Phenben/Ivermectin 148/4mg – 60 research tablets

This wholesale-only product contains 60 combination reference tablets labeled Phenben/Ivermectin 148/4mg. It is intended for approved research buyers conducting controlled identity, content-uniformity, dissolution, stability, or other analytical workflows. The label and lot label are the controlling references for exact composition.

Research applications

• Identity and content-verification methods
• Tablet dissolution, uniformity, and stability studies
• Comparative analytical and method-development workflows

Product specifications

• Label strength: 148/4mg
• Count: 60 tablets
• Access: approved wholesale research buyers only

Research use only. Not intended for human or animal use, consumption, administration, diagnosis, treatment, veterinary use, or any medical application.

Experimental design and evidence boundaries

Published observations involving this material may depend on model system, concentration, exposure interval, assay platform, controls, and material provenance. Results from biochemical, cellular, ex-vivo, or animal models should not be represented as evidence of human safety or clinical effectiveness. Researchers should document lot identity, solvent system, assay conditions, reference standards, and acceptance criteria before comparing results across studies.

Identity, purity, and traceability

Identity and purity should be evaluated against the lot-specific certificate of analysis and any available chromatographic or mass-spectrometric documentation. The product label and current COA control over general website information when specifications differ by lot.